Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kellie Komoda"'
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 21-27 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on the
Externí odkaz:
https://doaj.org/article/b422d669ee74416dacf2daf094cb1f9b
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 21-27 (2022)
Cancer Medicine
Cancer Medicine
Background Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on their infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b57c46cce3afb1f7c7d0f241d1c26e
https://doi.org/10.1002/cam4.4393
https://doi.org/10.1002/cam4.4393
1556. Infectious Disease Complications with Use of Checkpoint Inhibitors in Solid Organ Malignancies
Autor:
J. Ross, James I. Ito, Sanjeet Dadwal, Ravi Salgia, Sumanta K. Pal, Jana Dickter, Kellie Komoda, Kim Margolin
Publikováno v:
Open Forum Infectious Diseases
Background Immune checkpoint inhibitors (ICIs) are innovative cancer immunotherapies used for solid-organ and hematologic malignancies. ICIs are known for their immune-related adverse events (irAE) but there are limited reports on infectious complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646cb084900444dd9a355bf78234302a
http://europepmc.org/articles/PMC6252963
http://europepmc.org/articles/PMC6252963
Autor:
Ross, Justine Abella1 (AUTHOR) juross@coh.org, Komoda, Kellie1 (AUTHOR), Pal, Sumanta2 (AUTHOR), Dickter, Jana3 (AUTHOR), Salgia, Ravi2 (AUTHOR), Dadwal, Sanjeet3 (AUTHOR)
Publikováno v:
Cancer Medicine. Jan2022, Vol. 11 Issue 1, p21-27. 7p.